论文信息 - How to use implantable intrathecal drug delivery systems for refractory cancer pain.

How to use implantable intrathecal drug delivery systems for refractory cancer pain.

Dr. Smith is Professorand Chair of theDivision of Hematology/Oncology and PalliativeCare at the VirginiaCommonwealth UniversityHealth System, Richmond,Virginia.Mr. Coyne is Director ofClinical Services on theThomas Palliative CareUnit of the VirginiaCommonwealth UniversityHealth System, Richmond,Virginia.Correspondence to: Thomas J. Smith, MD, Division ofHematology/Oncology, Virginia CommonwealthUniversity, MCV Box 980230, Richmond, VA 23298-0230;telephone: (804) 828-9723; fax: (804) 828-8079;e-mail: tsmith@hsc.vcu.edu

Thomas J. Smith | P. Coyne

[1] N. Christakis,et al. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study , 2000, BMJ : British Medical Journal.

[2] P. Staats. Neuraxial infusion for pain control: when, why, and what to do after the implant. , 1999, Oncology.

[3] S. Hassenbusch,et al. Clinical realities and economic considerations: economics of intrathecal therapy. , 1997, Journal of pain and symptom management.

[4] G. Rolly,et al. Spinal analgesia in terminal care: risk versus benefit. , 1994, Journal of pain and symptom management.

[5] S. Hassenbusch,et al. Constant infusion of morphine for intractable cancer pain using an implanted pump. , 1990, Journal of neurosurgery.

[6] T. Yaksh,et al. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. , 1990, Journal of neurosurgery.

[7] R. Penn,et al. Chronic intrathecal morphine for intractable pain. , 1987, Journal of neurosurgery.

[8] N. Polissar,et al. Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.